Updated on 2024/04/20

写真a

 
SUGAI Akihiro
 
Organization
University Medical and Dental Hospital Neurology Lecturer
Title
Lecturer
External link

Degree

  • 博士(医学) ( 2015.3   新潟大学 )

Research Areas

  • Life Science / Neurology

Research History (researchmap)

  • 新潟大学医歯学総合病院   脳神経内科   講師

    2023.4

      More details

  • Niigata University   Brain Research Institute Center for Bioresources Brain Science Branch Department of Molecular Neuroscience   Assistant Professor

    2019.10 - 2023.3

      More details

  • Niigata University   Medical and Dental Hospital   Assistant Professor

    2019.4 - 2019.9

      More details

  • Niigata University   University Medical and Dental Hospital Advanced Disaster Medical and Emergency Critical Care Center   Specially Appointed Assistant Professor

    2017.11 - 2019.3

      More details

  • Niigata University   University Medical and Dental Hospital Neurology   Specially Appointed Assistant Professor

    2016.6 - 2017.10

      More details

  • Niigata University   University Medical and Dental Hospital Uonuma Institute of Community Medicine   Specially Appointed Assistant Professor

    2015.10 - 2016.3

      More details

▶ display all

Research History

  • Niigata University   University Medical and Dental Hospital   Lecturer

    2023.4

  • Niigata University   Brain Research Institute Center for Bioresources   Assistant Professor

    2019.12 - 2023.3

  • Niigata University   University Medical and Dental Hospital Neurology   Assistant Professor

    2019.4 - 2019.11

  • Niigata University   University Medical and Dental Hospital Advanced Disaster Medical and Emergency Critical Care Center   Specially Appointed Assistant Professor

    2017.11 - 2019.3

  • Niigata University   University Medical and Dental Hospital Neurology   Specially Appointed Assistant Professor

    2016.6 - 2017.10

  • Niigata University   University Medical and Dental Hospital UONUMA CHIIKI IRYO KYOIKU CENTER JUNBISHITU   Specially Appointed Assistant Professor

    2015.10 - 2016.3

▶ display all

 

Papers

  • The Multifaceted Regulation of TDP-43 Condensates at the Intersection of Physiology and Pathology: Implications for Neurodegenerative Diseases

    Akihiro Sugai, Takuma Yamagishi, Shingo Koide, Osamu Onodera

    Phase Separation in Living Cells   253 - 270   2023.9

     More details

    Authorship:Corresponding author   Publishing type:Part of collection (book)   Publisher:Springer Nature Singapore  

    DOI: 10.1007/978-981-99-4886-4_13

    researchmap

  • Age-related demethylation of the TDP-43 autoregulatory region in the human motor cortex Reviewed International journal

    Yuka Koike, Akihiro Sugai, Norikazu Hara, Junko Ito, Akio Yokoseki, Tomohiko Ishihara, Takuma Yamagishi, Shintaro Tsuboguchi, Mari Tada, Takeshi Ikeuchi, Akiyoshi Kakita, Osamu Onodera

    Communications Biology   4 ( 1 )   1107 - 1107   2021.12

     More details

    Authorship:Corresponding author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:Springer Science and Business Media LLC  

    <title>Abstract</title>In amyotrophic lateral sclerosis (ALS), TAR DNA-binding protein 43 (TDP-43), which is encoded by <italic>TARDBP</italic>, forms aggregates in the motor cortex. This aggregate formation may be triggered by an increase in the TDP-43 level with aging. However, the amount of TDP-43 is autoregulated by alternative splicing of the <italic>TARDBP</italic> 3′UTR, and how this autoregulation is affected by aging remains to be elucidated. We found that DNA demethylation in the autoregulatory region in the <italic>TARDBP</italic> 3′UTR reduced alternative splicing and increased <italic>TARDBP</italic> mRNA expression. Furthermore, in the human motor cortex, we found that this region was demethylated with aging, resulting in increased expression of <italic>TARDBP</italic> mRNA. The acceleration of DNA demethylation in the motor cortex was associated with the age of ALS onset. In summary, the dysregulation of TDP-43 autoregulation by age-related DNA demethylation in the motor cortex may explain the contribution of aging and motor system selectivity in ALS.

    DOI: 10.1038/s42003-021-02621-0

    PubMed

    researchmap

    Other Link: https://www.nature.com/articles/s42003-021-02621-0

  • Candesartan prevents arteriopathy progression in cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy model. Reviewed International journal

    Taisuke Kato, Ri-Ichiroh Manabe, Hironaka Igarashi, Fuyuki Kametani, Sachiko Hirokawa, Yumi Sekine, Natsumi Fujita, Satoshi Saito, Yusuke Kawashima, Yuya Hatano, Shoichiro Ando, Hiroaki Nozaki, Akihiro Sugai, Masahiro Uemura, Masaki Fukunaga, Toshiya Sato, Akihide Koyama, Rie Saito, Atsushi Sugie, Yasuko Toyoshima, Hirotoshi Kawata, Shigeo Murayama, Masaki Matsumoto, Akiyoshi Kakita, Masato Hasegawa, Masafumi Ihara, Masato Kanazawa, Masatoyo Nishizawa, Shoji Tsuji, Osamu Onodera

    The Journal of clinical investigation   131 ( 22 )   2021.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Cerebral small vessel disease (CSVD) causes dementia and gait disturbance due to arteriopathy. Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL) is a hereditary form of CSVD caused by loss of high-temperature requirement A1 (HTRA1) serine protease activity. In CARASIL, arteriopathy causes intimal thickening, smooth muscle cell (SMC) degeneration, elastic lamina splitting, and vasodilation. The molecular mechanisms were proposed to involve the accumulation of matrisome proteins as substrates or abnormalities in transforming growth factor β (TGF-β) signaling. Here, we show that HTRA1-/- mice exhibited features of CARASIL-associated arteriopathy: intimal thickening, abnormal elastic lamina, and vasodilation. In addition, the mice exhibited reduced distensibility of the cerebral arteries and blood flow in the cerebral cortex. In the thickened intima, matrisome proteins, including the hub protein fibronectin (FN) and latent TGF-β binding protein 4 (LTBP-4), which are substrates of HTRA1, accumulated. Candesartan treatment alleviated matrisome protein accumulation and normalized the vascular distensibility and cerebral blood flow. Furthermore, candesartan reduced the mRNA expression of Fn1, Ltbp-4, and Adamtsl2, which are involved in forming the extracellular matrix network. Our results indicate that these accumulated matrisome proteins may be potential therapeutic targets for arteriopathy in CARASIL.

    DOI: 10.1172/JCI140555

    PubMed

    researchmap

  • 加齢と関連したDNA脱メチル化がTDP-43量の自己調節機構を障害する

    小池 佑佳, 須貝 章弘, 原 範和, 伊藤 絢子, 横関 明男, 石原 智彦, 山岸 拓磨, 坪口 晋太朗, 他田 真理, 池内 健, 柿田 明美, 小野寺 理

    Dementia Japan   35 ( 4 )   610 - 610   2021.10

     More details

    Language:English   Publisher:(一社)日本認知症学会  

    researchmap

  • Refractory Myositis Affecting the Intrinsic Muscles of the Hand. Reviewed

    Kosei Nakamura, Akihiro Sugai, Etsuji Saji, Kensaku Kasuga, Osamu Onodera

    Internal medicine (Tokyo, Japan)   59 ( 9 )   1211 - 1214   2020.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Myositis generally affects the proximal muscles. However, we herein report a case of a 48-year-old woman with intractable myositis affecting the intrinsic muscles of the hands. Her myositis, which developed in childhood, was refractory to treatment with steroids and several immunosuppressants, causing walking disability. After experiencing pain and swelling in the hands for six months, she was diagnosed with myositis of the intrinsic muscles of the hands and tested positive for the anti-signal recognition particle antibody. Intravenous immunoglobulin therapy improved the myositis of the hands. This case suggests that inflammation caused by intractable myositis can extend to the hands.

    DOI: 10.2169/internalmedicine.3773-19

    PubMed

    researchmap

  • [Amyloid β-related angiitis presenting extensive brain involvement without detection of hemorrhagic lesions: A case report]. Reviewed

    Yuya Hatano, Akihiro Sugai, Takuma Yamagishi, Akihiro Nakajima, Akiyoshi Kakita, Osamu Onodera

    Rinsho shinkeigaku = Clinical neurology   60 ( 3 )   187 - 192   2020.3

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    In amyloid β-related angiitis, cortical or subcortical microbleeding or cortical superficial siderosis supports clinical diagnosis. However, here we present a 75-year-old female case of amyloid β-related angiitis that did not initially show these lesions. The patient developed right homonymous hemianopia and aphasia, and subsequently became comatose. Her brain lesions progressed extensively from the left occipital lobe to the bilateral cerebral hemispheres, with diffused leptomeningeal lesions and scattered DWI high-intensity lesions. After pathological diagnosis, steroid treatment improved her symptoms as well as imaging findings. No hemorrhagic lesions were detected in the T2*-weighted imaging performed before treatment. However, susceptibility-weighted imaging performed after treatment showed a number of lesions with microbleeding. The clinical features of amyloid β-related angiitis that do not show hemorrhagic lesions at onset should be investigated for rapid therapeutic intervention in the future.

    DOI: 10.5692/clinicalneurol.cn-001340

    PubMed

    researchmap

  • 出血性病変が検出されずに広範な脳病変に至ったアミロイドβ関連血管炎の1例 Reviewed

    畠野 雄也, 須貝 章弘, 山岸 拓磨, 中島 章博, 柿田 明美, 小野寺 理

    臨床神経学   60 ( 3 )   187 - 192   2020.3

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    アミロイドβ関連血管炎(amyloid β-related angiitis)では、皮質や皮質下の微小出血や脳表ヘモジデリンの沈着が、脳MRI上の重要な所見である。我々は、治療前にはこれらの所見を呈さなかったアミロイドβ関連血管炎を提示する。症例は75歳女性。右同名半盲と失語で発症し、昏睡に至った。脳MRIでは、びまん性の軟髄膜造影病変と散在性のDWI高信号病変を認めたが、T2*WIでは微小出血は検出されなかった。病理所見からアミロイドβ関連血管炎と診断した。ステロイド治療により画像所見、臨床症状ともに改善した。治療後のsusceptibility-weighted imaging(SWI)では多数の微小出血を認めた。アミロイドβ関連血管炎の非侵襲的診断のために、微小出血以外の画像の特徴を集積すべきである。(著者抄録)

    researchmap

    Other Link: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2020&ichushi_jid=J01550&link_issn=&doc_id=20200310190003&doc_link_id=130007822832&url=http%3A%2F%2Fci.nii.ac.jp%2Fnaid%2F130007822832&type=CiNii&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00003_1.gif

  • [Molecular mechanism of amyotrophic lateral sclerosis (ALS) from the viewpoint of the formation and degeneration of transactive response DNA-binding protein 43 kDa (TDP-43) inclusions]. Reviewed

    Sou Kasahara, Tomohiko Ishihara, Yuka Koike, Akihiro Sugai, Osamu Onodera

    Rinsho shinkeigaku = Clinical neurology   60 ( 2 )   109 - 116   2020.2

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    Sporadic amyotrophic lateral sclerosis (SALS) and many cases of familial ALS (FALS) demonstrate cytoplasmic transactive response DNA-binding protein 43 kDa (TDP-43)-positive inclusion bodies. Thus, TDP-43 plays a vital role in ALS pathogenesis. Functional analysis of the ALS causative genes advanced the elucidation of the mechanism associated with the formation and degradation of TDP-43 aggregates. Stress granules, which are non-membranous organelles, are attracting attention as sites of aggregate formation, with involvement of FUS and C9orf72. Concurrently, ALS causative genes related to the ubiquitin-proteasome and autophagy systems, which are aggregate degradation mechanisms, have also been reported. Therefore, therapeutic research based on the molecular pathology common to SALS and FALS has been advanced.

    DOI: 10.5692/clinicalneurol.cn-001362

    PubMed

    researchmap

  • Transactive response DNA-binding protein 43kDa(TDP-43)凝集体の形成と分解からみたamyotrophic lateral sclerosis(ALS)の分子機構 Reviewed

    笠原 壮, 石原 智彦, 小池 佑佳, 須貝 章弘, 小野寺 理

    臨床神経学   60 ( 2 )   109 - 116   2020.2

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    孤発性筋萎縮性側索硬化症(sporadic amyotrophic lateral sclerosis;SALS)、および多くの家族性ALS(familial ALS;FALS)において、神経細胞質内transactive response DNA-binding protein 43kDa(TDP-43)陽性の封入体を認める。この事実からTDP-43は本症の根幹に関わる分子である。ALS病因遺伝子の機能解析から、TDP-43の病的凝集体形成/分解に関わる発症メカニズムの解明が進められている。凝集体形成の場として、非膜性構造であるストレス顆粒が注目されており、FUSやC9orf72の関与が示されている。一方、凝集体分解機構であるユビキチン-プロテアソーム系、オートファジー系に関わるALS病因遺伝子も報告されている。SALSおよびFALSに共通する分子病態に対する治療研究が進められている。(著者抄録)

    researchmap

  • TAF15が主要に蓄積したFET病理を伴う筋萎縮性側索硬化症 剖検例の臨床病理学的特徴(Amsotrophic lateral sclerosis with TAF15-predominant FET pathology: clinicopathologic features of an autopsied patient)

    Cui Bo, Tada Mari, Hatano Yuya, Takeshima Akari, Ishihara Tomohiko, Sugai Akihiro, Tokutake Takayoshi, Kanazawa Masato, Onodera Osamu, Kakita Akiyoshi

    新潟医学会雑誌   133 ( 11-12 )   391 - 391   2019.12

  • 【ALS 2019】TDP-43封入体から解くALSの分子病態 Reviewed

    坪口 晋太朗, 石原 智彦, 須貝 章弘, 横関 明男, 小野寺 理

    BRAIN and NERVE: 神経研究の進歩   71 ( 11 )   1183 - 1189   2019.11

     More details

    Language:Japanese   Publisher:(株)医学書院  

    <文献概要>TDP-43蛋白質の封入体形成機構は,筋萎縮性側索硬化症(ALS)の主要な分子病態機序である。ALS原因遺伝子の機能解析から,TDP-43封入体形成にはストレス顆粒形成,蛋白質分解機構,TDP-43蛋白質の自己調節機構の破綻などが関わることが見出された。これらの解明された分子病態に基づく,ALS治療方法の確立が期待される。

    researchmap

  • [Molecular Pathogenesis of Amyotrophic Lateral Sclerosis]. Reviewed

    Shintaro Tsuboguchi, Tomohiko Ishihara, Akihiro Sugai, Akio Yokoseki, Osamu Onodera

    Brain and nerve = Shinkei kenkyu no shinpo   71 ( 11 )   1183 - 1189   2019.11

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)  

    The molecular pathogenesis of amyotrophic lateral sclerosis (ALS) has been studied through analysis of the function of the protein produced by the causative genes of familial ALS. The products of these genes are classified as RNA binding proteins, or proteins related to proteolytic systems. However, most case of familial ALS, and sporadic ALS show TAR DNA binding protein-43 (TDP-43) immune-positive cytoplasmic inclusions. Therefore, the molecular mechanism of formation of TDP-43 inclusions and dysfunction caused by TDP-43 inclusions has been studied. As for the mechanism of inclusion formation, non-membrane organelle formation by liquid-liquid phase separation (LLPS) is important. The ubiquitin-proteasome and autophagy systems are important for the degradation of these inclusions. Several genes associated with these systems have been identified as causative genes for ALS. The formation of cytoplasmic inclusions results in the loss of TDP-43 from the nucleus, resulting in abnormalities in RNA metabolism, through the alteration of spliceosomes and Gemini of coiled bodies. Furthermore, in ALS, the regulation of TDP-43 mRNA/protein expression levels has failed. Failure of the autoregulation system facilitates TDP-43 inclusion formation. Development of treatments for ALS based on these elucidated molecular mechanisms is desirable.

    DOI: 10.11477/mf.1416201428

    PubMed

    researchmap

  • Non-genetically modified models exhibit TARDBP mRNA increase due to perturbed TDP-43 autoregulation. Reviewed International journal

    Akihiro Sugai, Taisuke Kato, Akihide Koyama, Yuka Koike, Takuya Konno, Tomohiko Ishihara, Osamu Onodera

    Neurobiology of disease   130   104534 - 104534   2019.10

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)  

    Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by accumulation of fragmented insoluble TDP-43 and loss of TDP-43 from the nucleus. Increased expression of exogenous TARDBP (encoding TDP-43) induces TDP-43 pathology and cytotoxicity, suggesting the involvement of aberrant expression of TDP-43 in the pathogenesis of ALS. In normal conditions, however, the amount of TDP-43 is tightly regulated by the autoregulatory mechanism involving alternative splicing of TARDBP mRNA. To investigate the influence of autoregulation dysfunction, we inhibited the splicing of cryptic intron 6 using antisense oligonucleotides in vivo. This inhibition doubled the Tardbp mRNA expression, increased the fragmented insoluble TDP-43, and reduced the number of motor neurons in the mouse spinal cord. In human induced pluripotent stem cell-derived neurons, the splicing inhibition of intron 6 increased TARDBP mRNA and decreased nuclear TDP-43. These non-genetically modified models exhibiting rise in the TARDBP mRNA levels suggest that TDP-43 autoregulation turbulence might be linked to the pathogenesis of ALS.

    DOI: 10.1016/j.nbd.2019.104534

    PubMed

    researchmap

  • 【脳タンパク質老化と認知症制御】脳タンパク質とその標的RNAの均衡と破綻

    小池 佑佳, 須貝 章弘, 小野寺 理

    細胞   50 ( 6 )   303 - 306   2018.5

     More details

    Language:Japanese   Publisher:(株)ニュー・サイエンス社  

    神経変性疾患を特徴づける脳内に異常に蓄積するタンパク質には、RNA結合タンパク質が多く含まれる。RNA結合タンパク質は、タンパク質をコードするmRNAのみならず、mRNA前駆体のイントロン領域や非翻訳領域、さらにはノンコーディングRNAに対しても結合し、広範な細胞内機能を担っている。特定の脳タンパク質が異常に蓄積する神経変性疾患の病態を理解し、これを制御するためには、RNA結合タンパク質とこれと関連するRNA代謝の両面からのアプローチが必要となる。近年、RNA結合タンパク質とその標的RNAの量の不均衡が細胞毒性と関連することを示唆する報告が集まりつつある。RNA結合タンパク質と関連するRNAからなるロバストな細胞内制御機構の背後に潜む脆弱因子を特定し、制御することが、これらの脳疾患の克服につながるものと期待したい。(著者抄録)

    researchmap

  • Robustness and Vulnerability of the Autoregulatory System That Maintains Nuclear TDP-43 Levels: A Trade-off Hypothesis for ALS Pathology Based on in Silico Data. Reviewed International journal

    Akihiro Sugai, Taisuke Kato, Akihide Koyama, Yuka Koike, Sou Kasahara, Takuya Konno, Tomohiko Ishihara, Osamu Onodera

    Frontiers in neuroscience   12   28 - 28   2018

     More details

    Authorship:Lead author, Corresponding author   Language:English   Publishing type:Research paper (scientific journal)  

    Abnormal accumulation of TAR DNA-binding protein 43 (TDP-43) in the cytoplasm and its disappearance from the nucleus are pathological features of amyotrophic lateral sclerosis and frontotemporal dementia (ALS/FTD) and are directly involved in the pathogenesis of these conditions. TDP-43 is an essential nuclear protein that readily aggregates in a concentration-dependent manner. Therefore, cells must strictly maintain an appropriate amount of nuclear TDP-43. In one relevant maintenance mechanism, TDP-43 binds to its pre-mRNA and promotes alternative splicing, resulting in mRNA degradation via nonsense-mediated mRNA decay. The level of nuclear TDP-43 is tightly regulated by these mechanisms, which control the amount of mRNA that may be translated. Based on the results of previous experiments, we developed an in silico model that mimics the intracellular dynamics of TDP-43 and examined TDP-43 metabolism under various conditions. We discovered an inherent trade-off in this mechanism between transcriptional redundancy, which maintains the robustness of TDP-43 metabolism, and vulnerability to specific interfering factors. These factors include an increased tendency of TDP-43 to aggregate, impaired nuclear-cytoplasmic TDP-43 transport, and a decreased efficiency of degrading abnormal proteins, all of which are functional abnormalities related to the gene that causes familial ALS/FTD. When these conditions continue at a certain intensity, the vulnerability of the autoregulatory machinery becomes apparent over time, and transcriptional redundancy enters a vicious cycle that ultimately results in TDP-43 pathology. The results obtained using this in silico model reveal the difference in TDP-43 metabolism between normal and disease states. Furthermore, using this model, we simulated the effect of a decrease in TDP-43 transcription and found that this decrease improved TDP-43 pathology and suppressed the abnormal propagation of TDP-43. Therefore, we propose a potential therapeutic strategy to suppress transcriptional redundancy, which is the driving force of the pathological condition caused by the specific factors described above, in patients with ALS presenting with TDP-43 pathology. An ALS animal model exhibiting TDP-43 pathology without overexpression of exogenous TDP-43 should be developed to investigate the effect of alleviating the transcriptional redundancy of TARDBP.

    DOI: 10.3389/fnins.2018.00028

    PubMed

    researchmap

  • Increased cytoplasmic TARDBP mRNA in affected spinal motor neurons in ALS caused by abnormal autoregulation of TDP-43 Reviewed

    Akihide Koyama, Akihiro Sugai, Taisuke Kato, Tomohiko Ishihara, Atsushi Shiga, Yasuko Toyoshima, Misaki Koyama, Takuya Konno, Sachiko Hirokawa, Akio Yokoseki, Masatoyo Nishizawa, Akiyoshi Kakita, Hitoshi Takahashi, Osamu Onodera

    NUCLEIC ACIDS RESEARCH   44 ( 12 )   5820 - 5836   2016.7

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:OXFORD UNIV PRESS  

    Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disorder. In motor neurons of ALS, TAR DNA binding protein-43 (TDP-43), a nuclear protein encoded by TARDBP, is absent from the nucleus and forms cytoplasmic inclusions. TDP-43 auto-regulates the amount by regulating the TARDBP mRNA, which has three polyadenylation signals (PASs) and three additional alternative introns within the last exon. However, it is still unclear how the autoregulatory mechanism works and how the status of autoregulation in ALS motor neurons without nuclear TDP-43 is. Here we show that TDP-43 inhibits the selection of the most proximal PAS and induces splicing of multiple alternative introns in TARDBP mRNA to decrease the amount of cytoplasmic TARDBP mRNA by nonsense-mediated mRNA decay. When TDP-43 is depleted, the TARDBP mRNA uses the most proximal PAS and is increased in the cytoplasm. Finally, we have demonstrated that in ALS motor neurons-especially neurons with mislocalized TDP-43-the amount of TARDBP mRNA is increased in the cytoplasm. Our observations indicate that nuclear TDP-43 contributes to the autoregulation and suggests that the absence of nuclear TDP-43 induces an abnormal autoregulation and increases the amount of TARDBP mRNA. The vicious cycle might accelerate the disease progression of ALS.

    DOI: 10.1093/nar/gkw499

    Web of Science

    PubMed

    researchmap

  • 脳アミロイドアンギオパチー関連炎症のバイオマーカー、血中抗Aβ抗体の検討

    徳武 孝允, 関根 有美, 須貝 章弘, 赤岩 靖久, 本間 篤, 藤田 信也, 大野 司, 田中 晋, 西澤 正豊, 池内 健

    臨床神経学   53 ( 12 )   1574 - 1574   2013.12

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • 脳アミロイドアンギオパチー関連炎症の画像、臨床症状、バイオマーカーの検討

    徳武 孝允, 春日 健作, 須貝 章弘, 赤岩 靖久, 本間 篤, 藤田 信也, 大野 司, 田中 晋, 西澤 正豊, 池内 健

    Dementia Japan   27 ( 4 )   500 - 500   2013.10

     More details

    Language:Japanese   Publisher:(一社)日本認知症学会  

    researchmap

  • Hereditary Diffuse Leukoencephalopathy with Spheroids (HDLS): Clinical Characteristics and Molecular Analyses of CSF-1R Reviewed

    Konno Takuya, Tada Masayoshi, Koyama Akihide, Tada Mari, Sugai Akihiro, Nozaki Hiroaki, Matsunaga Akiko, Harigaya Yasuo, Nishimiya Jin, Ishihara Kenji, Yoneda Makoto, Kakita Akiyoshi, Takahashi Hitoshi, Kawamura Mitsuru, Onodera Osamu, Nishizawa Masatoyo, Ikeuchi Takeshi

    NEUROLOGY   80   2013.2

     More details

    Language:English   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Web of Science

    researchmap

  • マラソン中に心肺停止となり、蘇生後に筋緊張性ジストロフィーと診断された17歳男性例

    石黒 敬信, 須貝 章弘, 梅田 能生, 小宅 睦郎, 藤田 信也

    臨床神経学   53 ( 2 )   159 - 159   2013.2

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • Japanese amyotrophic lateral sclerosis patients with GGGGCC hexanucleotide repeat expansion in C9ORF72 Reviewed

    Takuya Konno, Atsushi Shiga, Akira Tsujino, Akihiro Sugai, Taisuke Kato, Kazuaki Kanai, Akio Yokoseki, Hiroto Eguchi, Satoshi Kuwabara, Masatoyo Nishizawa, Hitoshi Takahashi, Osamu Onodera

    Journal of Neurology, Neurosurgery and Psychiatry   84 ( 4 )   398 - 401   2013

     More details

    Language:English   Publishing type:Research paper (scientific journal)   Publisher:BMJ Publishing Group  

    Background A GGGGCC hexanucleotide repeat expansion in C9ORF72 occurs on a chromosome 9p21 locus that is linked with frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) in white populations. The diseases resulting from this expansion are referred to as 'c9FTD/ALS'. It has been suggested that c9FTD/ALS arose from a single founder. However, the existence of c9FTD/ALS in non-white populations has not been evaluated. Results We found two index familial ALS (FALS) patients with c9FTD/ALS in the Japanese population. The frequency of c9FTD/ALS was 3.4% (2/58 cases) in FALS. No patients with sporadic ALS (n=110) or control individuals (n=180) had the expansion. Neuropathological findings of an autopsy case were indistinguishable from those of white patients. Although the frequency of risk alleles identified in white subjects is low in Japanese, one patient had all 20 risk alleles and the other had all but one. The estimated haplotype indicated that the repeat expansion in these patients was located on the chromosome with the risk haplotype identified in white subjects. Conclusions C9ORF72 repeat expansions were present in a Japanese cohort of ALS patients, but they were rare. Intriguingly, Japanese patients appear to carry the same risk haplotype identified in white populations.

    DOI: 10.1136/jnnp-2012-302272

    Scopus

    PubMed

    researchmap

  • Neurolymphomatosis presenting as bilateral tongue atrophy: A case report Reviewed

    Akihiro Sugai, Takuya Konno, Toshio Yano, Maiko Umeda, Mutsuo Oyake, Nobuya Fujita

    Clinical Neurology   52 ( 8 )   589 - 591   2012.8

     More details

    Authorship:Lead author   Language:Japanese   Publishing type:Research paper (scientific journal)  

    A 62-year-old woman had progressive dysarthria for 2 months and was suspected of having amyotrophic lateral sclerosis because of the presentation of bilateral tongue atrophy and fasciculation. Brain magnetic resonance imaging (MRI) showed enlargement of the left hypoglossal nerve, and whole-body gallium scintigraphy showed abnormal uptake in the left pelvic cavity and left thigh. On the basis of the findings of biopsy of the mass lesion in the left thigh, she was diagnosed with diffuse large B-cell lymphoma. After chemotherapy for diffuse large B-cell lymphoma, the tongue atrophy improved. The patient subsequently developed left oculomotor nerve palsy, weakness of the right arm, and weakness of the right leg. The cause of these symptoms was thought to be neurolymphomatosis on the basis of the typical MRI findings observed. We report a rare case of neurolymphomatosis presenting as bilateral tongue atrophy, mimicking amyotrophic lateral sclerosis.

    DOI: 10.5692/clinicalneurol.52.589

    Scopus

    PubMed

    researchmap

    Other Link: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2012&ichushi_jid=J01550&link_issn=&doc_id=20120809240010&doc_link_id=10.5692%2Fclinicalneurol.52.589&url=https%3A%2F%2Fdoi.org%2F10.5692%2Fclinicalneurol.52.589&type=J-STAGE&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00007_3.gif

  • 両側舌萎縮で発症した悪性リンパ腫の62歳女性例

    永野 教嗣, 須貝 章弘, 今野 卓哉, 小宅 睦郎, 藤田 信也

    臨床神経学   52 ( 8 )   602 - 602   2012.8

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • 免疫グロブリン大量療法が奏功したmotor dominant CIDPの35歳男性例

    畠山 公大, 今野 卓哉, 須貝 章弘, 小宅 睦郎, 藤田 信也

    臨床神経学   52 ( 5 )   372 - 372   2012.5

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • プリオン蛋白遺伝子codon180とcodon232の両方に変異を認めたCreutzfeldt-Jakob病の臨床像の検討

    須貝 章弘, 今野 卓哉, 梅田 麻衣子, 小宅 睦郎, 松原 奈絵, 小池 涼子, 藤田 信也

    臨床神経学   51 ( 12 )   1342 - 1342   2011.12

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • CMV感染後のギラン・バレー症候群では早期のIVIgとmPSLパルス併用療法が有効である

    今野 卓哉, 須貝 章弘, 梅田 麻衣子, 小宅 睦郎, 楠 進, 藤田 信也

    臨床神経学   51 ( 12 )   1380 - 1380   2011.12

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • 首下がりを契機に診断された甲状腺機能亢進症の61歳女性例

    木村 成宏, 須貝 章弘, 今野 卓哉, 小宅 睦郎, 藤田 信也

    臨床神経学   51 ( 8 )   633 - 633   2011.8

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • 両側前腕の激痛で発症した脊髄梗塞の62歳男性例

    川田 亮, 須貝 章弘, 今野 卓哉, 小宅 睦郎, 藤田 信也

    臨床神経学   51 ( 7 )   522 - 522   2011.7

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • 髄膜脳炎が先行したつつが虫病の63歳男性例

    今野 卓哉, 須貝 章弘, 梅田 麻衣子, 小宅 睦郎, 藤田 信也

    臨床神経学   51 ( 5 )   390 - 390   2011.5

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • Atypical MRI Findings of Wernicke Encephalopathy in Alcoholic Patients

    Akihiro Sugai, Koki Kikugawa

    AMERICAN JOURNAL OF ROENTGENOLOGY   195 ( 5 )   W372 - W373   2010.11

     More details

    Authorship:Lead author   Language:English   Publishing type:Research paper (scientific journal)   Publisher:AMER ROENTGEN RAY SOC  

    DOI: 10.2214/AJR.10.4539

    Web of Science

    PubMed

    researchmap

  • MRワクチン接種後に左軟口蓋麻痺を呈した1例

    笹川 朋子, 須貝 章弘, 赤岩 靖久, 徳武 孝允, 高野 弘基, 西澤 正豊

    新潟医学会雑誌   123 ( 7 )   373 - 373   2009.7

  • A case of orbital apex syndrome caused by invasive aspergillosis successfully treated during the diagnostic procedure by the use of voriconazole Reviewed

    Akihiro Sugai, Mutsuo Oyake, Maiko Umeda, Yoshitaka Umeda, Nobuya Fujita

    Clinical Neurology   48 ( 10 )   746 - 749   2008

     More details

    Authorship:Lead author   Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:Societas Neurologica Japonica  

    A 75-year-old woman developed loss of vision and decreased ocular motility in all directions. She exhibited a left orbital apex syndrome, accompanied by sphenoiditis and hypertrophic pachymeningitis. Voriconazole treatment was initiated on the basis of clinical suspicion, although use of the serum β-D glucan had negative results and a biopsy was not performed. Five days later, the left eye movements started to improve, and at that time the use of the serum aspergillus galactomannan antigen proved to have positive results. Six months later, the patient was neurologically intact and stable, except for a lack of visual acuity in counting fingers. Earlier prognoses of invasive sino-orbital aspergillosis were dismal, especially when corticosteroid therapy was done before diagnosis. This case suggests the usefulness of antifungal agents during the diagnostic procedure even when localized invasive aspergillosis is not ruled out.

    DOI: 10.5692/clinicalneurol.48.746

    Scopus

    PubMed

    researchmap

▶ display all

MISC

  • TDP-43変異型により異なる病態進展特性の解析

    森秀樹, 坪口晋太朗, 佐藤時春, 中村由香, 加藤泰介, 須貝章弘, 小野寺理, 上野将紀

    Dementia Japan   37 ( 4 )   2023

  • 加齢と関連したDNA脱メチル化がTDP-43量の自己調節機構を障害する

    小池佑佳, 須貝章弘, 原範和, 伊藤絢子, 横関明男, 石原智彦, 山岸拓磨, 坪口晋太朗, 他田真理, 池内健, 柿田明美, 小野寺理

    Dementia Japan   35 ( 4 )   2021

  • 抗GD1aIgM抗体と抗GT1bIgM抗体が陽性で免疫グロブリン療法が奏功した遠位優位型CIDPの76歳男性例

    羽入 龍太郎, 須貝 章弘, 加藤 怜, 秋山 夏葵, 徳武 孝允, 金澤 雅人, 河内 泉, 小野寺 理

    臨床神経学   60 ( 1 )   87 - 87   2020.1

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • 抗GD1aIgM抗体と抗GT1bIgM抗体が陽性で免疫グロブリン療法が奏功した遠位優位型CIDPの76歳男性例

    羽入 龍太郎, 須貝 章弘, 加藤 怜, 秋山 夏葵, 徳武 孝允, 金澤 雅人, 河内 泉, 小野寺 理

    臨床神経学   60 ( 1 )   87 - 87   2020.1

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • 手内筋にまで炎症が波及し免疫グロブリン大量静注療法が奏功した難治性筋炎の51歳女性例

    中村 航世, 須貝 章弘, 春日 健作, 徳武 孝允, 小野寺 理

    臨床神経学   59 ( 9 )   615 - 615   2019.9

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • 病理学的に同定した進行性の白質病変を認めた脳アミロイドβ関連血管炎の2症例

    北原 匠, 上村 昌博, 柳村 文博, 畠野 雄也, 須貝 章弘, 河内 泉, 柿田 明美, 小野寺 理

    Dementia Japan   32 ( 3 )   482 - 482   2018.9

     More details

    Language:Japanese   Publisher:(一社)日本認知症学会  

    researchmap

  • T2*強調画像で微小出血を認めず、軟髄膜病変が急速に拡大したアミロイドβ関連血管炎の75歳女性例

    畠野 雄也, 須貝 章弘, 山岸 拓磨, 中島 章博, 他田 正義, 河内 泉, 小野寺 理

    臨床神経学   58 ( 8 )   529 - 529   2018.8

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • 【脳タンパク質老化と認知症制御】 脳タンパク質とその標的RNAの均衡と破綻

    小池 佑佳, 須貝 章弘, 小野寺 理

    細胞   50 ( 6 )   303 - 306   2018.5

     More details

    Language:Japanese   Publisher:(株)ニュー・サイエンス社  

    神経変性疾患を特徴づける脳内に異常に蓄積するタンパク質には、RNA結合タンパク質が多く含まれる。RNA結合タンパク質は、タンパク質をコードするmRNAのみならず、mRNA前駆体のイントロン領域や非翻訳領域、さらにはノンコーディングRNAに対しても結合し、広範な細胞内機能を担っている。特定の脳タンパク質が異常に蓄積する神経変性疾患の病態を理解し、これを制御するためには、RNA結合タンパク質とこれと関連するRNA代謝の両面からのアプローチが必要となる。近年、RNA結合タンパク質とその標的RNAの量の不均衡が細胞毒性と関連することを示唆する報告が集まりつつある。RNA結合タンパク質と関連するRNAからなるロバストな細胞内制御機構の背後に潜む脆弱因子を特定し、制御することが、これらの脳疾患の克服につながるものと期待したい。(著者抄録)

    researchmap

  • 三叉神経節から脊髄路核までMRIで造影効果を伴う病変を認め、バラシクロビルが奏功した38歳男性例

    加藤 怜, 須貝 章弘, 山岸 拓磨, 他田 正義, 河内 泉, 小野寺 理

    臨床神経学   58 ( 4 )   253 - 253   2018.4

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • 三叉神経節から脊髄路核までMRIで造影効果を伴う病変を認め、バラシクロビルが奏功した38歳男性例

    加藤 怜, 須貝 章弘, 山岸 拓磨, 他田 正義, 河内 泉, 小野寺 理

    臨床神経学   58 ( 4 )   253 - 253   2018.4

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • T2<sup>*</sup>強調画像で微小出血を認めず,軟髄膜病変が急速に拡大したアミロイドβ関連血管炎の75歳女性例

    畠野雄也, 須貝章弘, 山岸宅磨, 中島章博, 他田正義, 河内泉, 小野寺理

    臨床神経学(Web)   58 ( 8 )   2018

  • ALS原因遺伝子TDP-43の点変異によるアレル特異的遺伝子発現の変化

    須貝 章弘, 廣川 祥子, 小山 哲秀, 今野 卓哉, 小野寺 理

    生命科学系学会合同年次大会   2017年度   [3P - 1118]   2017.12

     More details

    Language:Japanese   Publisher:生命科学系学会合同年次大会運営事務局  

    J-GLOBAL

    researchmap

  • 繰り返しの髄液検査で診断し得た経過3年のクリプトコッカス性髄膜脳炎の1例

    大津 裕, 須貝 章弘, 茂木 崇秀, 若杉 尚宏, 眞島 卓弥, 他田 正義, 下畑 享良, 小野寺 理

    臨床神経学   57 ( 10 )   632 - 632   2017.10

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • 感覚性運動失調型ニューロパチーと鑑別を要した脊椎疾患の2例

    畠野 雄也, 金澤 雅人, 林 秀樹, 青山 あずさ, 須貝 章弘, 徳武 孝允, 下畑 享良, 小野寺 理

    パーキンソン病・運動障害疾患コングレスプログラム・抄録集   11回   102 - 102   2017.10

     More details

    Language:Japanese   Publisher:Movement Disorder Society of Japan (MDSJ)  

    J-GLOBAL

    researchmap

  • 筋萎縮性側索硬化症の病態モデル 自己蛋白量調節機構の破綻による内在性TDP-43の過剰発現

    須貝 章弘

    新潟医学会雑誌   129 ( 11 )   658 - 670   2015.11

     More details

    Language:Japanese   Publisher:新潟医学会  

    筋萎縮性側索硬化症(amyotrophic lateral sclerosis:ALS)患者の運動神経細胞およびグリア細胞の細胞質内には、TAR DNA-binding protein 43kDa(TDP-43)陽性の封入体を認める。このTDP-43発現量が、ALS患者で亢進しているとの報告がある。一方、核内蛋白であるTDP-43は自己蛋白量調節機構を有しており、通常の状態ではこの過剰は起こり得ない。著者は、この自己蛋白量調節機構の破綻がTDP-43過剰発現および神経細胞障害を引き起こすとの仮説を立て、この自己蛋白量調節機構の破綻による内在性TDP-43過剰発現モデルを構築し、この仮説を検証することを本研究の目的とした。これまでに著者らは、外来性TDP-43過剰発現細胞の解析により、TDP-43エクソン6内の近位選択的イントロンのスプライシングが発現抑制に重要であることを示してきた。本研究では、この選択的スプライシングをモルフォリノアンチセンス核酸により特異的に抑制し、発現抑制機構を破綻させることにより、内在性TDP-43過剰発現状態を誘導することに成功した。さらに、成体マウス髄腔内へのアンチセンス核酸の投与により、脊髄組織においても内在性TDP-43発現を増加させた。これらの結果は、TDP-43発現抑制機構におけるこの選択的スプライシングの意義を決定づけるとともに、この破綻による内在性TDP-43過剰モデルを細胞およびマウス個体において構築したことを意味する。さらに、この内在性TDP-43過剰発現マウスでは、ALS罹患組織でみられるTDP-43C末断片の増加、さらにアポトーシス促進因子であるBIMの発現増加を認めた。これらより、TDP-43エクソン6内の選択的スプライシング効率の減弱は、内在性TDP-43の過剰発現を導き、神経細胞障害を引き起こすことが示唆された。この内在性TDP-43過剰発現モデルが、ALS病態のさらなる解明と治療法開発に貢献することが期待される。(著者抄録)

    CiNii Article

    CiNii Books

    researchmap

    Other Link: http://hdl.handle.net/10191/44293

  • 核内TDP-43減少は細胞質内TDP-43 mRNA増加をもたらす

    須貝 章弘, 小山 哲秀, 加藤 泰介, 今野 卓哉, 石原 智彦, 西澤 正豊, 小野寺 理

    臨床神経学   54 ( Suppl. )   S62 - S62   2014.12

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • ALS関連TARDBP遺伝子変異は自身の選択的スプライシングに影響をおよぼすか?

    今野 卓哉, 小山 哲秀, 逸見 文昭, 小山 美咲, 須貝 章弘, 加藤 泰介, 石原 智彦, 西澤 正豊, 小野寺 理

    臨床神経学   54 ( Suppl. )   S200 - S200   2014.12

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • 脳アミロイドアンギオパチー関連炎症の臨床症状、画像、バイオマーカーの多様性の検討

    笠原 壮, 徳武 孝允, 春日 健作, 須貝 章弘, 赤岩 靖久, 本間 篤, 小池 佑佳, 藤田 信也, 大野 司, 田中 晋, 西澤 正豊, 池内 健

    臨床神経学   54 ( Suppl. )   S13 - S13   2014.12

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • 神経変性疾患に関する調査研究 TDP-43 mRNAのポリA選択とスプライシングを介した自己蛋白量の制御機構

    小野寺理, 須貝章弘, 小山哲秀, 加藤泰介, 志賀篤, 今野卓哉, 小山美咲, 石原智彦, 西澤正豊

    神経変性疾患に関する調査研究 平成25年度 総括・分担研究報告書   2014

  • 【神経症候群(第2版)-その他の神経疾患を含めて-】血管障害 その他 遺伝性脳小血管病 Retinal vasculopathy with cerebral leukodystrophy(RVCL)

    須貝 章弘, 西澤 正豊, 小野寺 理

    日本臨床   別冊 ( 神経症候群I )   312 - 313   2013.12

     More details

    Language:Japanese   Publisher:(株)日本臨床社  

    researchmap

  • TDP-43量はTDP-43に惹起される自己mRNAのスプライシングで制御される

    須貝 章弘, 小山 哲秀, 今野 卓哉, 加藤 泰介, 西澤 正豊, 小野寺 理

    臨床神経学   53 ( 12 )   1411 - 1411   2013.12

     More details

    Language:Japanese   Publisher:(一社)日本神経学会  

    researchmap

  • HDLS(hereditary diffuse leukoencephalopathy with spheroids)のMRI所見

    今野 卓哉, 須貝 章弘, 西澤 正豊, 他田 正義, 小野寺 理, 他田 真理, 野崎 洋明, 小山 哲秀, 池内 健

    新潟医学会雑誌   127 ( 6 )   334 - 334   2013.6

  • 視交叉に腫瘤性病変を認めたNMO(neuromyelitis optica) spectrum disorderの1例

    柳村 文寛, 梅田 能生, 須貝 章弘, 小宅 睦郎, 藤田 信也

    神経内科   78 ( 5 )   570 - 574   2013.5

     More details

    Language:Japanese   Publisher:(有)科学評論社  

    症例は80歳女性で、9ヵ月前に視界が万華鏡のようになり頭痛も伴ったため他院を受診し両耳側半盲を指摘され、プレドニゾロン(PSL)内服で視力は回復した。今回PSL内服を中止したところ急速に視力が低下し、更に頭部MRIで視交叉に造影病変が認められたため、精査加療目的に当院紹介となった。入院時、視力は両眼とも光覚なく、対光反射は遅鈍で、血清学的に抗アクアポリン4抗体が陽性であった。また髄液検査でタンパク、IgG index、ミエリン塩基性タンパクの上昇を認め、視覚誘発電位検査では両側とも波形は導出不良であった。頭部MRI FLAIR画像で視交叉に高信号病変を認め、更にT2強調画像で脳脊髄液と同等の高信号、T1強調画像で灰白質と比べて低信号を示し、腫大が認められた。左側脳室体部近傍白質にも小病変を認め、視神経限局型視神経脊髄炎spectrum disorderと診断した。ステロイドパルス療法2コース施行しPSLによる後療法を行ったところ、約1ヵ月半後の頭部MRIで視交叉と左側脳室体部近傍白質の造影病変の消失を認め、新聞の文字の判読は困難なものの、人の顔はわかるようになった。

    researchmap

  • What is the key player in TDP-43 pathology in ALS: Disappearance from the nucleus or inclusion formation in the cytoplasm?

    Osamu Onodera, Akihiro Sugai, Takuya Konno, Mari Tada, Akihide Koyama, Masatoyo Nishizawa

    NEUROLOGY AND CLINICAL NEUROSCIENCE   1 ( 1 )   11 - 17   2013.1

     More details

    Language:English   Publishing type:Book review, literature introduction, etc.   Publisher:WILEY  

    C9ORF72 and the 43 kDa TAR DNA-binding protein (TDP-43) are key molecules in the development of TDP-43 pathology in amyotrophic lateral sclerosis (ALS). The hexanucleotide repeat expansion in C9ORF72 also leads to frontotemporal lobar degeneration, whereas mutation of TARDBP mainly causes ALS, indicating that TDP-43 plays a more fundamental role in the development of ALS. In tissues affected with ALS, TDP-43 is dislocated from the nucleus, forms cytoplasmic inclusions, and is phosphorylated and truncated. Accumulating evidence suggests that the disappearance of TDP-43 from the nucleus precedes inclusion formation, indicating that its disappearance from the nucleus is crucial in the development of TDP-43 pathology. Alterations in the quality and quantity of TDP-43 might result in the disappearance of TDP-43 from the nucleus. Regarding quality, phosphorylation and truncation of TDP-43 is not necessary for its disappearance from the nucleus or for inclusion formation. Although it has been speculated that studies of TDP-43 harboring ALS-associated mutations are useful for understanding the molecular pathogenesis of sporadic ALS, the functional and biochemical differences between mutated and wild-type TDP-43 remain unclear. Regarding quantity, an increased amount of TDP-43 is an attractive hypothesis as it has been shown that increased amounts of TDP-43 are toxic. Moreover, several reports have suggested that increased levels of TDP-43 are found in sporadic ALS as well as in ALS with TDP-43 mutations. However, these findings remain controversial. Increased understanding of the mechanisms responsible for regulating TDP-43 will provide a basis for determining the molecular pathogenesis of ALS.

    DOI: 10.1002/ncn3.9

    Web of Science

    researchmap

  • 筋萎縮性側索硬化症の分子病態解明と新規治療法創出に関する研究 TDP-43 mRNAの制御機構

    小野寺理, 小山哲秀, 須貝章弘, 今野卓哉, 小山美咲, 石原智彦, 西澤正豊

    筋萎縮性側索硬化症の分子病態解明と新規治療法創出に関する研究 平成22-24年度 総合研究報告書   2013

  • 脳アミロイドアンギオパチー関連炎症の臨床的多様性 画像所見、APOE、血中抗Aβ抗体

    須貝 章弘, 石井 賢二, 赤岩 靖久, 本間 篤, 藤田 信也, 田中 晋, 豊原 潤, 石渡 喜一, 西澤 正豊, 池内 健

    Dementia Japan   26 ( 4 )   501 - 501   2012.10

     More details

    Language:Japanese   Publisher:(一社)日本認知症学会  

    researchmap

  • Clinicopathological Features of Patients with Dermatomyositis with Subcutaneous Edema

    Akihiro Sugai, Tetsuya Takahashi, Takayoshi Shimohata, Masatoyo Nishizawa

    NEUROLOGY   74 ( 9 )   A184 - A184   2010.3

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:LIPPINCOTT WILLIAMS & WILKINS  

    Web of Science

    researchmap

  • 早期の単純血漿交換が奏効した卵巣奇形腫非合併抗NMDAR脳炎の1例

    今野卓哉, 津田勝路, 目崎直実, 須貝章弘, 梅田麻衣子, 梅田能生, 小宅睦郎, 藤田信也

    Neuroinfection   15 ( 2 )   2010

  • 病初期に急性小脳炎様の経過をとった傍腫瘍性小脳変性症の2例

    目崎直実, 今野卓哉, 須貝章弘, 梅田麻衣子, 梅田能生, 小宅睦郎, 藤田信也

    Neuroinfection   15 ( 2 )   2010

  • 運動失調と意識障害を伴った横紋筋融解症がレジオネラ肺炎の顕在化に先行した1例

    須貝 章弘, 梅田 能生, 成瀬 聡, 藤田 信也

    神経内科   66 ( 6 )   584 - 588   2007.6

     More details

    Language:Japanese   Publisher:(有)科学評論社  

    53歳男性。運動失調と意識障害を伴った横紋筋融解症がレジオネラ肺炎の顕在化に先行した1例を経験した。発熱、歩行不安定感があり、自宅近くを歩行中ふらついて転倒し、動けなくなり救急搬送された。体温40.3℃、著明な発汗、意識レベルはJCS I-1、立位が不安定で体幹失調を認め、CRP、GOT、GPT、ALP、LDH、γ-GPT、CK、尿中ミオグロビンの高値、低酸素血症を認めた。X線で左下葉に軽度の浸潤影を認めた。横紋筋融解症と診断し、セフトリアキソン点滴静注を開始したが、翌日にはPaO2がさらに低下し、X線上左肺野全体に濃度上昇があり胸水の出現が示唆され、CKのさらなる上昇、不穏や多弁、見当織障害を認めた。レジオネラ尿中迅速抗原検査で陽性所見を得て、抗生剤をメシル酸パズフロキサシンとエリスロマイシンの点滴静注に変更し、呼吸状態、炎症所見、CK値は速やかに改善した。意識障害の回復と運動失調も消失し、入院23日目に独歩退院した。

    researchmap

▶ display all

Awards

Research Projects

  • 脳小血管線維化促進細胞の同定による脳小血管老化の解明

    Grant number:22H02981

    2022.4 - 2025.3

    System name:科学研究費助成事業

    Research category:基盤研究(B)

    Awarding organization:日本学術振興会

    加藤 泰介, 須貝 章弘

      More details

    Grant amount:\17290000 ( Direct Cost: \13300000 、 Indirect Cost:\3990000 )

    researchmap

  • 選択的スプライシングの操作により天然変性領域を制御するALS治療戦略の検証

    Grant number:20K07880

    2020.4 - 2023.3

    System name:科学研究費助成事業

    Research category:基盤研究(C)

    Awarding organization:日本学術振興会

    須貝 章弘

      More details

    Grant amount:\4290000 ( Direct Cost: \3300000 、 Indirect Cost:\990000 )

    本研究の目的は、筋萎縮性側索硬化症の病原性タンパク質における天然変性領域の機能的かつ病的意義を明らかにすることにより、筋萎縮性側索硬化症の革新的な治療法の開発につなげることにある。天然変性領域は、特定の構造をもたないフラフラした領域であり、これにより、多様な分子との相互作用が可能になり、RNA顆粒などの膜をもたないオルガネラを形成する液-液相分離の形成に関わっている。しかし、このフレキシブルな構造は、一方で、線維化・凝集化のリスクをもつ。天然変性領域を介した液-液相分離と凝集は、神経変性疾患の異常タンパク質の蓄積を説明する病態として、近年、殊に注目を集めている。
    本研究で着目する天然変性領域は、選択的スプライシングを受ける領域によりコードされる。これまでに、この選択的スプライシングを修飾する因子について、明らかにしてきた。これには、RNA配列、エピジェネティクス因子、RNA結合タンパク質が含まれる。これらの基礎的知見の上に、当該年度は、この選択的スプライシングを制御するための複数の標的配列を見出した。マウスモデルを用いた天然変性領域の制御効果を検証する実験計画は、予定通りに進行している。また、天然変性タンパク質の精製と凝集評価の系を確立し、分子生化学的な解析を進めている。これらの成果は、筋萎縮性側索硬化症の治療法の開発に向けた学術的な基盤を提供するものであり、今後の発展が期待される。

    researchmap

  • Therapeutic strategy for ALS with nucleic acid technology focusing on the vulnerability of TDP-43 autoregulation

    Grant number:17K09751

    2017.4 - 2020.3

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Scientific Research (C)

    Awarding organization:Japan Society for the Promotion of Science

    Sugai Akihiro

      More details

    Grant amount:\4680000 ( Direct Cost: \3600000 、 Indirect Cost:\1080000 )

    In amyotrophic lateral sclerosis (ALS), the nuclear protein TDP-43 accumulates in the cytoplasm. TDP-43 binds to its pre-mRNA, induces alternative splicing, and autoregulates its expression levels. Here, we first constructed a mathematical model and predicted that transcriptional redundancy that underpins TDP-43 autoregulation could drive TDP-43 pathology. Then, we used an antisense oligo to suppress TDP-43 alternative splicing and manifested transcriptional redundancy. As a result, in the mouse spinal cord, the increase and fragmentation of insoluble TDP-43 and decrease in the number of motor neurons were observed. These results, which recapitulate part of the ALS pathology, suggested that this alternative splicing could be a promising therapeutic target for ALS.

    researchmap

  • Modeling ALS with TDP-43 proteinopathy

    Grant number:15H06225

    2015.8 - 2017.3

    System name:Grants-in-Aid for Scientific Research

    Research category:Grant-in-Aid for Research Activity Start-up

    Awarding organization:Japan Society for the Promotion of Science

    Sugai Akihiro

      More details

    Grant amount:\2990000 ( Direct Cost: \2300000 、 Indirect Cost:\690000 )

    Accumulation of TDP-43 in the cytoplasm of motor neurons is a pathological hallmark of amyotrophic lateral sclerosis (ALS). TDP-43 regulates its own mRNA expression. We recently elucidated that a redundant transcription followed by alternative splicing of the pre-mRNA is a critical process for the auto-regulation and that TDP-43 mRNA is increased in ALS motor neurons. Based on this finding, we disturbed the alternative spicing and developed a model with increased intrinsic TDP-43 in mice spinal cords and in human iPS-cell derived neurons.

    researchmap